9-cis β-carotene Inhibits Atherosclerosis Development in Female LDLR-/- Mice

Authors

  • Noa Zolberg Relevy The Bert W. Strassburger Lipid Center; Sheba Medical Center, Tel-Hashomer, 5265601 Israel; The Mina and Everard Goodman Faculty of Life Science, Bar-Ilan University, Ramat-Gan, Israel
  • Ralph Rühl Department of Biochemistry and Molecular Biology, University of Debrecen, Debrecen, Hungary
  • Ayelet Harari The Bert W. Strassburger Lipid Center; Sheba Medical Center, Tel-Hashomer, 5265601 Israel
  • Itamar Grosskopf The Bert W. Strassburger Lipid Center; Sheba Medical Center, Tel-Hashomer, 5265601 Israel
  • Iris Barshack Institute of Pathology, Sheba Medical Center, Tel-Hashomer; Sackler Faculty of Medicine, Tel-Aviv University, Israel
  • Ami Ben-Amotz N.B.T Israel
  • Uri Nir The Mina and Everard Goodman Faculty of Life Science, Bar-Ilan University, Ramat-Gan, Israel
  • Hugo Gottlieb Department of Chemistry, Bar-Ilan University, Ramat-Gan 52900, Israel.
  • Yehuda Kamari The Bert W. Strassburger Lipid Center; Sheba Medical Center, Tel-Hashomer, 5265601 Israel; Sackler Faculty of Medicine, Tel-Aviv University, Israel;
  • Dror Harats The Bert W. Strassburger Lipid Center; Sheba Medical Center, Tel-Hashomer, 5265601 Israel; Sackler Faculty of Medicine, Tel-Aviv University, Israel;
  • Aviv Shaish The Bert W. Strassburger Lipid Center; Sheba Medical Center, Tel-Hashomer, 5265601 Israel

DOI:

https://doi.org/10.31989/ffhd.v5i2.172

Abstract

Background: Several epidemiological studies have shown that diets rich in carotenoids are associated with a reduced risk of cardiovascular disease. However, administration of synthetic all-trans b-carotene was reported to have no effect on cardiovascular disease. We previously showed that the 9-cis b-carotene-rich powder of the alga Dunaliella bardawil inhibits atherogenesis and reduces plasma non-HDL cholesterol levels in mice.

Context and purpose of this study: We sought to study whether isolated 9-cis b-carotene inhibits atherogenesis in a murine model of atherosclerosis.

Results: Twelve-week-old female LDL receptor knockout mice (LDLR-/-) were pretreated for  2 weeks with regular chow diet fortified with the alga Dunaliella powder, 9-cis β-carotene isomer, all-trans β-carotene isomer, or 9-cis retinoic acid, followed by 10 weeks of a high-fat diet with the same fortifications. In contrast to Dunaliella, 9-cis β-carotene did not inhibit the high fat diet-induced elevation of plasma cholesterol. In addition, diet fortification with Dunaliella powder, β-carotene isomers, or 9-cis retinoic acid did not change the plasma retinol or retinoic acid levels. Nevertheless, 9-cis β-carotene significantly inhibited atherogenesis compared to the control mice (39% reduction).

Conclusions: The results suggest that 9-cis β-carotene should be considered as an anti-atherogenic agent in the human diet.

Key words: Atherosclerosis, Dunaliella, 9CBC, LDLR-/- mice 

 

Downloads

Published

2015-02-15

Issue

Vol. 5 No. 2 (2015): February 2015

Section

Research Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.